<qa>  What is the purpose of this study?The purpose of this study is to assess adherence, tolerability and satisfaction of each eligible HIV subjects switching from a two- or three-pill tenofovir-emtricitabine-efavirenz TDF-FTC-EFV to a one-pill TDF-FTC-EFV treatment. 